A new report published by Connect in Pharma highlights a range of forces shaping the future of the pharmaceutical manufacturing and drug-delivery fields, from machine learning and connected devices to eco-friendly strategies.
Amin Sikander, Synkrato co-founder & president, examines the trends within pharma manufacturing that will incur as its processes become smarter, more data-driven and transparent.
Editor, Rebekah Jordan, reviews pharma's transformation to digital solutions, and how the industry will need to navigate the associated risks to prevent breaches in security and safety.
Last Thursday, chancellor Jeremy Hunt announced new measures for smoother medicine approvals in the UK, increased support for R&D, and a simplified tax system for SMEs. UK biotech company, Nevrargenics shared its position on the 2023 Budget.
Editor, Rebekah Jordan, sat with Mark Bagnall, CEO of Phenomix Sciences, to understand how the company is redefining the way obesity disease is treated with precision medicine to allow for better treatment decisions and patient outcomes.
Chris Johnson, managing director at pharmaceutical bearing supplier, SMB Bearings, explains the importance of considered design choices and obsolescence management in pharmaceutical manufacturing.
Lee Feander, senior director with Alvarez & Marsal Healthcare and Life Sciences practice, explores the three areas that pharmaceutical companies need to address to better tackle the current UK drug shortage.
Gabrielle Gehron, scientific support manager, Datwyler, explains how to successfully analyse your pharma packaging needs and navigate through the packaging selection process.
Dr. Carmen Guguta, Technobis Crystallization Systems, explores how laboratories can do more complex experiments with small amounts of material by using benchtop analytical technology.
Stefan Duerr, sr. director, head of the Cenduit Drug Supply Center of Excellence, and IQVIA business, explains how a flexible and innovative approach to Interactive Response Technology (IRT) can help navigate today's clinical trial landscape.
Shivshankar S.R, CEO of ACG Films and Foils, delves into the ESG strategy that ACG is implementing to improve its organisational sustainability and the requirements needed to ensure its success: education, communication and innovation.
